Sunbird Bio is revolutionising disease detection with its APEX technology, which allows for the direct detection of disease-specific proteins linked to Alzheimer’s, Parkinson’s, and other neurological disorders through a simple blood test. This non-invasive diagnostic approach sets them apart from existing methods, which struggle to differentiate between healthy and disease-specific proteins. Sunbird Bio's commitment to innovation, integrity, resilience, and teamwork drives their mission to address critical gaps in diagnostics. With expertise in blood-based diagnostics and a global vision, Sunbird Bio is poised to make a significant impact on both research and clinical markets.